Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

The anti-vaccination movement and resistance to allergen-immunotherapy: a guide for clinical allergists.

Behrmann J.

Allergy Asthma Clin Immunol. 2010 Sep 15;6(1):26. doi: 10.1186/1710-1492-6-26.

2.
3.
4.

Knowledge, attitudes, and beliefs of school nurses and personnel and associations with nonmedical immunization exemptions.

Salmon DA, Moulton LH, Omer SB, Chace LM, Klassen A, Talebian P, Halsey NA.

Pediatrics. 2004 Jun;113(6):e552-9.

PMID:
15173536
5.

New strategies for allergen immunotherapy.

Carnés J, Robinson DS.

Recent Pat Inflamm Allergy Drug Discov. 2008 Jun;2(2):92-101. Review.

PMID:
19075996
6.
7.

Incorrect allergy injections: allergists' experiences and recommendations for prevention.

Aaronson DW, Gandhi TK.

J Allergy Clin Immunol. 2004 Jun;113(6):1117-21.

PMID:
15208593
8.

Latex allergy: a model for therapy.

Rolland JM, O'Hehir RE.

Clin Exp Allergy. 2008 Jun;38(6):898-912. doi: 10.1111/j.1365-2222.2008.02984.x. Review.

PMID:
18498539
9.

From allergen genes to new forms of allergy diagnosis and treatment.

Vrtala S.

Allergy. 2008 Mar;63(3):299-309. doi: 10.1111/j.1398-9995.2007.01609.x. Review.

10.

Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.

Valenta R, Vrtala S, Focke-Tejkl M, Bugajska-Schretter, Ball T, Twardosz A, Spitzauer S, Grönlund H, Kraft D.

Biol Chem. 1999 Jul-Aug;380(7-8):815-24. Review.

PMID:
10494830
11.

Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.

Senti G, Johansen P, Haug S, Bull C, Gottschaller C, Müller P, Pfister T, Maurer P, Bachmann MF, Graf N, Kündig TM.

Clin Exp Allergy. 2009 Apr;39(4):562-70. doi: 10.1111/j.1365-2222.2008.03191.x.

PMID:
19226280
12.

Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.

Young MD, Gooch WM 3rd, Zuckerman AJ, Du W, Dickson B, Maddrey WC.

J Med Virol. 2001 Jul;64(3):290-8.

PMID:
11424117
13.

Allergy shots for hay fever.

Galant SP.

Postgrad Med. 1989 May 1;85(6):203-9. Review.

PMID:
2469078
14.

Strategies for converting allergens into hypoallergenic vaccine candidates.

Vrtala S, Focke-Tejkl M, Swoboda I, Kraft D, Valenta R.

Methods. 2004 Mar;32(3):313-20. Review.

PMID:
14962766
15.

Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation.

O'Hehir RE, Sandrini A, Anderson GP, Rolland JM.

Curr Med Chem. 2007;14(21):2235-44. Review.

PMID:
17896972
16.

Towards immunotherapy for peanut allergy.

Pons L, Palmer K, Burks W.

Curr Opin Allergy Clin Immunol. 2005 Dec;5(6):558-62. Review.

PMID:
16264338
17.

The clinician's guide to the anti-vaccinationists' galaxy.

Poland GA, Jacobson RM.

Hum Immunol. 2012 Aug;73(8):859-66. Review.

PMID:
22504410
18.

Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.

Focke M, Swoboda I, Marth K, Valenta R.

Clin Exp Allergy. 2010 Mar;40(3):385-97. doi: 10.1111/j.1365-2222.2009.03443.x.

PMID:
20210812
19.

Allergen immunotherapy: current and new therapeutic strategies.

Rolland JM, Douglass J, O'Hehir RE.

Expert Opin Investig Drugs. 2000 Mar;9(3):515-27. Review.

PMID:
11060692
20.

DNA-based vaccines for allergic disease.

Spiegelberg HL, Takabayashi K, Beck L, Raz E.

Expert Rev Vaccines. 2002 Aug;1(2):169-77. Review.

PMID:
12901556
Items per page

Supplemental Content

Support Center